BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10516928)

  • 1. [Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
    Arita K; Daido K; Ohashi N; Nakamura K; Takeshima Y; Kohara T
    Jpn J Antibiot; 1999 Jul; 52(7):491-6. PubMed ID: 10516928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
    Kinoshita S; Kumagai S
    Jpn J Antibiot; 1998 Sep; 51(9):551-60. PubMed ID: 9846282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
    Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
    Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa.
    Shigemi A; Matsumoto K; Yaji K; Shimodozono Y; Takeda Y; Miyanohara H; Kawamura H; Orita M; Tokuda K; Nishi J; Yamada K
    Int J Antimicrob Agents; 2009 Dec; 34(6):589-91. PubMed ID: 19748231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs].
    Watanabe Y; Fujiue Y; Yano S; Shimizu S; Muroki K; Doi M; Kuwabara M
    Jpn J Antibiot; 2006 Apr; 59(2):65-71. PubMed ID: 16805317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
    Fujiue Y; Kuwabara M; Muroki K; Shimizu S; Watanabe Y; Awaya Y; Kodomari Y
    Jpn J Antibiot; 1998 Jan; 51(1):26-36. PubMed ID: 9557274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
    Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
    J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of antibiotics by the method of initial bactericidal activity].
    Matsuda K; Inoue M
    Jpn J Antibiot; 2000 Dec; 53(12):667-71. PubMed ID: 11234223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial activities of meropenem against clinically isolated strains in 1997].
    Suzuki Y; Matsumoto Y; Nishinari C; Endo H; Ishihara R; Deguchi K
    Jpn J Antibiot; 1999 Dec; 52(12):695-720. PubMed ID: 10695025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
    Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S
    J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial activities and mechanisms of carbapenem resistance in clinical isolates of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp].
    Sugino Y; Iinuma Y; Nada T; Tawada Y; Amano H; Nakamura T; Hasegawa Y; Shimokata K; Shibata N; Arakawa Y
    Kansenshogaku Zasshi; 2001 Aug; 75(8):662-70. PubMed ID: 11558128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2004].
    Yamaguchi K; Murakami M; Takahashi A; Ishii Y; Iwata M; Itoh K; Oohara T; Watanabe N; Uehara N; Nomura F; Watanabe M; Yasujima M; Kasai T; Kanno H; Aihara M; Suwabe A; Yamahata K; Maesaki S; Hashikita G; Kaku M; Kanemitsu K; Miyake K; Oguri T; Yoshida H; Nishiyama K; Okada J; Tazawa Y; Komatsu M; Nakashima H; Takemura H; Kinoshita S; Okada M; Kobayashi S; Taminato T; Negayama K; Horii T; Murase M; Miyamoto H; Baba H; Kusano N; Mihara E; Ishigo S; Kambe M; Itaha H; Fujita N; Komori T; Ono J; Yoshimura H; Ichiyama S; Maeda S; Hirakata Y; Matsuda J; Yamanaka K; Mutara Y; Saikawa T; Hiramatsu K; Taminato S
    Jpn J Antibiot; 2005 Dec; 58(6):655-89. PubMed ID: 16521347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Christenson JC; Korgenski EK; Daly JA
    J Antimicrob Chemother; 2000 Jun; 45(6):899-901. PubMed ID: 10837448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.
    Sakyo S; Tomita H; Tanimoto K; Fujimoto S; Ike Y
    J Antibiot (Tokyo); 2006 Apr; 59(4):220-8. PubMed ID: 16830889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid bactericidal activities of carbapenems against Pseudomonas aeruginosa in simulating human plasma concentrations].
    Ishii C; Kakuta M; Abe T; Fukuoka T; Inoue M
    Jpn J Antibiot; 2002 Apr; 55(2):187-95. PubMed ID: 12071096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bactericidal activity of biapenem against various bacteria].
    Hiraishi T; Miyata A; Hara T; Araake M; Ogawa H
    Jpn J Antibiot; 2001 Dec; 54(12):581-95. PubMed ID: 11877858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of biapenem against recent clinical isolates].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):138-41. PubMed ID: 12825414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
    Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
    Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.